The Effect of Phentermine and B12 on Weight Loss Among Obese Patients

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study designed to test the hypothesis that the combination of phentermine and B12 will result in significantly greater weight loss among obese patients compared to phentermine alone.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Dr. Michael Lang
• Treatments: Phentermine; Vitamin B 12

Criteria

Individuals can participate in the study if they meet the following inclusion criteria:

• Are over the age of 18

• Have a BMI between 30 and 40

• Have a controlled blood pressure

• Do not have a B12 deficiency

• Are willing to take birth control (if female and not sterile or through menopause)

• Are English speaking

Individuals should not participate in if any of the following apply to them:

• Are not over the age of 18

• Do not have a BMI between 30 and 40

• Do not have a controlled blood pressure

• Have a B12 deficiency

• Females who are pregnant, trying to get pregnant, or not willing to use a method of birth control to ensure they do not become pregnant

• Individuals who do not speak English

• Individuals currently taking Adderall, Ritalin, or any other stimulant medication

• Individuals who have taken phentermine more than once in the past, or within 3 months of study initiation